Reported Reactions

Devices › Device types

FDA product code DYE · class 3 · Cardiovascular

Replacement heart-valve: medical device reports filed with FDA

37,240 reports carry this product code, 1992–2026; 30 brands with a page.

37,240
reports with this product code
0.1% of all MAUDE reports
1,916
reports, 12 months to August 2026
3,492 in the 12 months before
3.5%
classified as malfunction
62.3% across all reports
3.6%
classified as death, as reported
0.9% across all reports

Product code DYE is FDA's classification for "Replacement heart-valve" (cardiovascular panel), a class 3 device. 37,240 medical device reports carry this product code, 0.1% of the MAUDE database, from January 1992 to August 2026.

1,916 reports arrived in the 12 months to August 2026, down 45% from 3,492 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (92.7%), death (3.6%) and malfunction (3.5%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis8,1894952.6%2.1%
Carpentier-Edwards PERIMOUNT Magna Mitral Ease Pericardial Bioprosthesis3,9022331%1.4%
Carpentier-Edwards Perimount Magna Pericardial Bioprosthesis3,488537.7%2.9%
Carpentier-Edwards Perimount Rsr Pericardial Bioprosthesis2,604133.3%1.8%
Mosaic Aortic Bioprosthetic Heart Valve2,1134052.8%8.4%
Carpentier-Edwards PERIMOUNT Plus Pericardial Bioprosthesis2,093188.7%1.8%
Mosaic1,9241310.5%3%
Carpentier-Edwards Perimount Theon Pericardial Bioprosthesis1,641463.9%3%
Carpentier-Edwards Perimount Aortic Pericardial Bioprosthesis86177.1%3.2%
Carpentier-Edwards Perimount Magna Mitral Ease Pericardial Bioprostheses82303.8%4.9%
Carpentier-Edwards Perimount Magna Mitral Pericardial Bioprosthesis794112.9%4.5%
Mosaic Mitral Bioprosthetic Heart Valve7501546.4%7.2%
Ni6461,5871.8%29.5%
Carpentier-Edwards Perimount Magna Aortic Bioprosthesis6011127.1%1.8%
Carpentier-Edwards Bioprosthesis23435%0.6%
Mosaic Porcine Heart Valve202110.6%0.6%
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial aortic Bioprosthesis1883231.4%0%
Carpentier-Edwards Perimount Pericardial Aortic Bioprosthesis16771.2%3%
Mitroflow Aortic Pericardial Heart Valve167016.8%1.8%
Carpentier-Edwards Perimount Pericardial Bioprosthesis142110%0.6%
Edwards Prima Plus Stentless Bioprosthesis11002.6%2%
Hancock103221.5%1.7%
Perceval Sutureless Aortic Heart Valve66189.1%2.3%
Edwards INSPIRIS RESILIA Aortic Valve335990.8%0.9%
EDWARDS INTUITY ELITE Valve System26622.2%1.6%
Asku222101.1%47.1%
INSPIRIS RESILIA Aortic Valve22870.4%5.6%
Carpentier-Edwards Physio Annuloplasty Ring1707.8%0.5%
Medtronic Hall Prosthetic Heart Valve16019.8%32.4%
Avalus Aortic Tissue Valve1313311%16.4%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Edwards Lifesciences30,43681.7%
Medtronic Heart Valves Division5,61115.1%
Medtronic Heart Valve Division3510.9%
Livanova Canada1370.4%
Medtronic Heart Valves920.2%
Medtronic Mexico420.1%
Heart Valves Santa Ana230.1%
Sorin Group Italia140%
Guidant Vascular Intervention40%
Medtronic40%
St Jude Medical30%
Cryolife20%
Alcon Research /Huntington10%
Bard Access Systems10%

Reports by month, five years

0214427Sep 2021: 213Oct 2021: 209Nov 2021: 251Dec 2021: 2502022Jan 2022: 161Feb 2022: 179Mar 2022: 245Apr 2022: 282May 2022: 185Jun 2022: 189Jul 2022: 186Aug 2022: 187Sep 2022: 197Oct 2022: 208Nov 2022: 276Dec 2022: 2712023Jan 2023: 222Feb 2023: 247Mar 2023: 323Apr 2023: 231May 2023: 277Jun 2023: 357Jul 2023: 279Aug 2023: 427Sep 2023: 264Oct 2023: 285Nov 2023: 272Dec 2023: 3052024Jan 2024: 243Feb 2024: 289Mar 2024: 294Apr 2024: 262May 2024: 303Jun 2024: 312Jul 2024: 306Aug 2024: 287Sep 2024: 263Oct 2024: 289Nov 2024: 302Dec 2024: 2852025Jan 2025: 328Feb 2025: 284Mar 2025: 257Apr 2025: 278May 2025: 344Jun 2025: 289Jul 2025: 271Aug 2025: 302Sep 2025: 324Oct 2025: 227Nov 2025: 123Dec 2025: 1292026Jan 2026: 129Feb 2026: 141Mar 2026: 155Apr 2026: 126May 2026: 123Jun 2026: 155Jul 2026: 144Aug 2026: 140

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death3.6%1,342
Injury92.7%34,505
Malfunction3.5%1,310
Other0%9
Not given0.2%74

Who filed

Manufacturer report99.2%36,951
Voluntary report0.5%182
User facility report0%0
Distributor report0%0
Not given0.3%107

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Insufficient device problem information14,46438.8%
Gradient increase6,15016.5%
Calcified5,24114.1%
Degraded4,77112.8%
Device stenosis2,6457.1%
Fluid/blood leak2,4456.6%
Incomplete coaptation1,7474.7%
Perivalvular leak1,5744.2%
Patient device interaction problem1,3153.5%
Intravalvular regurgitation1,1933.2%
Difficult to open or close6061.6%
Inadequacy of device shape and/or size3791%
Structural problem3070.8%
Material split, cut or torn2780.7%
Deterioration of prosthesis2120.6%
Leak/splashthe device leaked1820.5%
Patient-device incompatibilitythe device did not suit the patient1820.5%
Thickening of material1370.4%
Torn material1140.3%
Breakthe device broke1040.3%

Questions about replacement heart-valve reports

What is product code DYE?

FDA's classification code for "Replacement heart-valve", class 3, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.

How many reports carry this code?

37,240 reports through August 2026, 1,916 of them in the latest 12 months.

Which brands appear most often?

Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis (8,189), Carpentier-Edwards PERIMOUNT Magna Mitral Ease Pericardial Bioprosthesis (3,902), Carpentier-Edwards Perimount Magna Pericardial Bioprosthesis (3,488), Carpentier-Edwards Perimount Rsr Pericardial Bioprosthesis (2,604) and Mosaic Aortic Bioprosthetic Heart Valve (2,113). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.